citalopram has been researched along with Liver Dysfunction in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Escitalopram has low protein binding (56%) and is not likely to cause interactions with highly protein-bound drugs." | 2.44 | The clinical pharmacokinetics of escitalopram. ( Rao, N, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Torres, E | 1 |
| Lucena, MI | 1 |
| Seoane, J | 1 |
| Verge, C | 1 |
| Andrade, RJ | 1 |
| Areberg, J | 1 |
| Christophersen, JS | 1 |
| Poulsen, MN | 1 |
| Larsen, F | 1 |
| Molz, KH | 1 |
| Rao, N | 1 |
1 review available for citalopram and Liver Dysfunction
| Article | Year |
|---|---|
The clinical pharmacokinetics of escitalopram.
Topics: Adolescent; Adult; Age Factors; Aged; Anxiety Disorders; Child; Citalopram; Depression; Drug Interac | 2007 |
2 other studies available for citalopram and Liver Dysfunction
| Article | Year |
|---|---|
Hepatotoxicity related to citalopram.
Topics: Adult; Chemical and Drug Induced Liver Injury; Citalopram; Depressive Disorder; Humans; Liver; Liver | 2004 |
The pharmacokinetics of escitalopram in patients with hepatic impairment.
Topics: Adult; Aged; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Citalopram; Cytochrome P-450 CYP2C19; | 2006 |